Immediate Impact
6 by Nobel laureates 40 from Science/Nature 65 standout
Citing Papers
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
2016 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Works of S Kiesel being referenced
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
1986
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| S Kiesel | 92 | 197 | 86 | 161 | 123 | 13 | 429 | |
| Volker Diehl | 79 | 163 | 140 | 177 | 200 | 23 | 492 | |
| Justus Duyster | 100 | 140 | 69 | 168 | 144 | 11 | 482 | |
| PA Jr Bunn | 54 | 73 | 124 | 139 | 151 | 11 | 466 | |
| G. Tolksdorf | 120 | 247 | 147 | 240 | 115 | 9 | 497 | |
| G. P. Clein | 50 | 101 | 122 | 100 | 73 | 12 | 388 | |
| V. Guigou | 158 | 214 | 48 | 71 | 76 | 12 | 374 | |
| J. J. Sotto | 164 | 154 | 116 | 151 | 130 | 13 | 377 | |
| Sherri Brown | 43 | 190 | 52 | 52 | 136 | 11 | 394 | |
| Catherine S. Rangel | 39 | 174 | 118 | 298 | 135 | 17 | 452 | |
| Rapp Mj | 41 | 88 | 75 | 101 | 183 | 9 | 414 |
All Works
Loading papers...